Niagen Bioscience, Inc. (NAGE)

Market Cap	857.25M
Revenue (ttm)	107.93M
Net Income (ttm)	14.11M
Shares Out	78.94M
EPS (ttm)	0.18
PE Ratio	60.68
Forward PE	83.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	234,492
Open	10.87
Previous Close	10.82
Day's Range	10.60 - 10.89
52-Week Range	2.31 - 11.16
Beta	1.95
Analysts	Strong Buy
Price Target	12.00 (+10.5%)
Earnings Date	May 7, 2025

About NAGE

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and ph...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 104
• Stock Exchange: NASDAQ
• Ticker Symbol: NAGE
• Website: https://www.niagenbioscience.com

Analyst Forecast

According to 2 analysts, the average rating for NAGE stock is "Strong Buy." The 12-month stock price forecast is $12.0, which is an increase of 10.50% from the latest price.

Price Target

$12.0

(10.50% upside)

Analyst Consensus: Strong Buy